Awesome piece in JACC Journals on brain MRI lesions post-TAVR No analysis I can offer above Dr. Samir Kapadia editorial, but wonder why not/if studies have been done on long term eval? Especially as TAVR moves to younger populations, exec cognitive function is relevant right?

Incredible place! Remember this day 10 years ago Weill Cornell Medicine well Congrats to all!

Finally! It’s about time If this sticks, a major win for patients and the healthcare system as a whole cnbc.com/2024/08/15/med…

Awesome work in Circulation More support for MRAs. Gotta love papers that focus on benefits with good, affordable drugs we already have Also love the ongoing support for naming trials. MAGMA? Well done ahajournals.org/doi/10.1161/CI…

It’s pretty wild how strenuously people will avoid paying $7/month on a subscription they somewhat value, then go to dinner and drop $100 without hesitation There’s gotta be some study on this, let me know if aware

🚨 New mini-series alert! 🚨 Check out inaugural @cardionerds #CardioRheum episode: The Role of Inflammation in Cardiovascular Disease with expert AntonioAbbate + Gurleen Kaur, MD, Ronaldo Correa Fabiano, Richard Ferraro 🔗Audio, pearls & notes🔗 cardionerds.com/387-cardio-rhe…

Same pass rate as echo boards. 1/5 failing. Means 1 of 2 things (welcome thoughts): 1) The test is not reflective of the true knowledge base required to competently practice in the field 2) Programs nationwide are failing to adequate prepare trainees for practice Which is it?

Register for #TCT2024 to meet the leaders of interventional cardiology Dr Roxana Mehran and David J. Cohen, MD, MSc and to learn from them . Richard Ferraro Bailey Ann Estes Ritu Thamman MD Abdel Almanfi, MD, FACC, FSCAI Alex Truesdell Hazim El-Haddad, MD sumonroy BCaseMD Garima Sharma M.D

Paper to save and file, maybe forever, in JACC Journals this week Awesome #CardioX discussion of interventions in HF Structural Cardiac Interventions in Patients With Heart Failure: JACC Scientific Statement | Journal of the American College of Cardiology

The 2nd podcast episode in the CardioNerds' SGLT Inhibition series is now available! This episode features Muthu Vaduganathan discussing the data supporting SGLT inhibition. Check it out: ow.ly/WcSe50T53Xz Unrestricted educational support for this series provided by Lexicon.

Main takeaway from this highly debated chart: IM is still a great way to go And from there you’re got great options (but cardiology is awesome, obviously)

Announcing a new Prevention podcast series w/ CardioNerds! The Cardio-Rheumatology series delves into the role of inflammation in CVD! Episode 1 features AntonioAbbate: ow.ly/Eezi50T54in Unrestricted educational support for this series provided by Agepha Pharma.

So 1st thing: Stop-or-Not is a top 5 trial name of 2024. Great name, congrats #ESCongress2024 2nd, major results for peri-operative management! No sig diff in outcomes as in figure, though ⬆️ in hypotension with RAS continuation (HR 1.31). Suspect this complicates things

Prevention of Cardiovascular Disease — Don’t Stop Thinking about Tomorrow | NEJM nejm.org/doi/full/10.10… Outstanding editorial by friends and colleagues on long term risk of CVD Johns Hopkins Cardiology Johns Hopkins Ciccarone Center Roger Blumenthal @sethshaymart Johns Hopkins Department of Medicine NEJM

Amazing to see my first The Osler Medical Residency CCU senior, now a senior cardiology fellow at ColumbiaCardiology, Fatimah Alkhunaizi presenting her cutting edge translational work on the immune system in NICM at a standing room only session at European Society of Cardiology!

FINE-ARTS #ESC2024 results very exciting. We really do have options for pts with HFpEF now, incredible Notable this was presented in Europe though. As a US provider, I’m tired of limiting my enthusiasm by a “How are we going to get this paid for” feeling Thoughts? Am I wrong?

🔥 Following up on Tarek Harb’s fantastic presentation on intraindividual variability in #lpa doi.org/10.1093/ehjope… at #ESC2024, today he delved into 🧬 PPAR-gamma's regulation of Lp(a) gene expression in HepG2 cells. Sam Tsimikas, MD Paul Mason MD Maciej Banach National Lipid Association

#ESC2024 SHAM-PVI is really exciting. I wasn't aware this sort of trial could get done Great work, looking forward to discussion of results and impact on practice! jamanetwork.com/journals/jama/…

Studying for #CardioTwitter boards: Not sure there’s a worse question than screening intervals. Can’t reason it, not really applicable to practice because you’d look it up in 2 minutes, just memorization Recs? How do you manage these? (I’ll be putting some things together soon)

Alright team, getting on the same page Infographic on screening & surgery recs for heritable diseases from 2022 ACC/AHA Aorta guidelines Making these for myself #Cardiology boards, but hope helps in general. Hopefully more of these to come Thoughts always appreciated